title: [Heavy silicone oil (Densiron® 68) in proliferative vitreoretinopathy: 4 years of experience].
abstract: METHODS
  Prospective observational study including 10 patients (age range: 27-74 years) with recurrent retinal detachment (RD) and proliferative vitreoretinopathy (PVR) and 2.8 mean unsatisfactory previous surgeries. Densiron® was injected in all patients, with surgical retinectomy being required in 70% of them. Minimum follow-up time was 12 months.
  
  
  RESULTS
  The mean length of time before Densiron® withdrawal was 4 months. Three patients (30%) presented with a new RD. The main complication detected was cataract development. No relationship was found between re-detachments and tamponade time, baseline disease or RD evolution time. Densiron® may be a good option in cases of recurrent RD in which previous treatment with scleral buckle, gas and/or 1,000/5,000 silicone oils has proven to be unsatisfactory.
authors.affiliation: Servicio de Oftalmología, Hospital Donostia, Donostia-San Sebastián, España. Electronic address: beatriz19es@hotmail.com.
authors.forename: B
authors.initials: B
authors.lastname: Macías-Murelaga
authors.forename: M
authors.initials: M
authors.lastname: Ruiz
authors.forename: L
authors.initials: L
authors.lastname: Bascarán
authors.forename: A
authors.initials: A
authors.lastname: Gibelalde
authors.forename: M
authors.initials: M
authors.lastname: Aldazabal
authors.forename: C
authors.initials: C
authors.lastname: Irigoyen
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012827:Silicone Oils / Q000627:therapeutic use*; D013997:Time Factors; D018630:Vitreoretinopathy, Proliferative / Q000188:drug therapy*
chemical_list: D012827:Silicone Oils; C515608:densiron
keywords: Aceite de silicona pesado; Densiron 68; Desprendimiento de retina; Heavy silicone oil; Proliferaciones vitreorretinianas; Proliferative vitreoretinopathy; Retinal detachment; Tamponade; Tamponador